Latest Competition News

Page 43 of 502
Antipa Minerals completed its CY2025 drilling program at the Minyari Gold-Copper Project, revealing new high-grade zones and boosting its Mineral Resource Estimate to 3.6 million ounces gold equivalent. The company is progressing its Pre-Feasibility Study and has commenced a major new drilling campaign, supported by a strong cash position.
Maxwell Dee
Maxwell Dee
28 Apr 2026
Icetana AI reported a 51% year-on-year jump in annual recurring revenue to $2.6 million but faced a $1.2 million net operating cash outflow in Q3 FY26, prompting plans for a capital raise amid expected cash flow improvements.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Atomos has finalized its acquisition of Flanders Scientific for $2.35 million cash plus shares, funded by a new $10 million finance facility from Commonwealth Bank. The deal broadens Atomos’ professional video monitoring reach and is expected to add $1 million EBITDA before growth.
Sophie Babbage
Sophie Babbage
27 Apr 2026
PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.
Ada Torres
Ada Torres
27 Apr 2026
Chimeric Therapeutics' CHM CORE-NK cell therapy achieved a 60% complete response rate in high-risk frontline AML patients, significantly exceeding typical outcomes and maintaining a strong safety profile.
Ada Torres
Ada Torres
27 Apr 2026
IperionX has transitioned its Virginia titanium operations to continuous 24/7 production, ramping proprietary HAMR™ titanium powder output to 4.2 metric tons in March and targeting 200 tons per annum by the end of 2026. Alongside manufacturing capacity expansions and strong U.S. Department of War backing, the company advances its critical minerals project in Tennessee.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.
Ada Torres
Ada Torres
27 Apr 2026
Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.
Ada Torres
Ada Torres
27 Apr 2026
Alliance Nickel is pursuing capital cost savings at its NiWest Nickel-Cobalt Project through vat leaching trials while reporting promising gold assay results from initial drilling at Australia United. A $4.15 million entitlement offer aims to fund these efforts amid ongoing offtake renegotiations with Stellantis.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Megaport’s Latitude.sh has secured a $35.4 million three-year compute and storage deal, adding nearly $12 million in annual recurring revenue and underpinning the company’s growth in AI-driven infrastructure.
Sophie Babbage
Sophie Babbage
27 Apr 2026
NEXTDC has launched the retail tranche of its A$1.5 billion fully underwritten entitlement offer at A$12.70 per share, aiming to back accelerated data centre capacity growth amid unprecedented contracted utilisation.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Mandrake Resources has identified overlapping placer claims staked by Utah Brine Corporation, linked to Neometals Ltd, on its Utah Lithium Project tenure. Legal demands have been issued to resolve the dispute, which affects a small portion of Mandrake’s 3.3Mt LCE resource.
Maxwell Dee
Maxwell Dee
24 Apr 2026